The Impact of Telemedicine on Sexual Medicine at a Major Academic Center During the COVID-19 Pandemic.
Care
Male Sexual Impotence
Outpatient
Populations
SARS-CoV-2
Telemedicine
Urology
Vulnerable
Journal
Sexual medicine
ISSN: 2050-1161
Titre abrégé: Sex Med
Pays: England
ID NLM: 101631053
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
24
01
2021
revised:
15
03
2021
accepted:
20
03
2021
pubmed:
29
5
2021
medline:
29
5
2021
entrez:
28
5
2021
Statut:
ppublish
Résumé
Telemedicine has the potential to improve access to care; however, its utility in the field of sexual medicine remains in question. To examine the importance of video visits for the treatment of male sexual medicine at our academic center during the period of peak telemedicine use in April 2020. We collected and compared deidentified data from all nonprocedure, adult outpatient encounters conducted as either office visits in April 2019 (n = 1,949) or video visits in April 2020 (n = 608). The primary International Classification of Diseases codes (ICD-10) labeled as diagnoses from all encounters were collected, with most encounters linked to several disease codes (n = 4,584). Demographic data were also collected. We performed comparative analyses on Stata (College Station, TX, USA) with significance set at α = .05. Disease codes were categorized based on their use and classification in urological care and the proportion that each category made up within the outpatient practice was calculated. In comparison to the office visits, which took place in April 2019, male sexual medicine visits in April 2020, during the peak of telemedicine use, made up a significantly larger overall share of our practice (P = .012), defined by relative rises in encounters pertaining to male hypogonadism, infertility, penile abnormalities, and testicular abnormalities. Outpatients seen over video visits were also younger than outpatients seen during the previous year over office visits (58.9 vs 60.8, P = .008). Further, race and ethnicity characteristics in the outpatient population were unaffected during the period of telemedicine use. During the period of historically high telemedicine use following the SARS-CoV-2 outbreak, encounters associated with male sexual medicine made up a significantly larger portion of our outpatient practice. Although the full influence of the COVID-19 pandemic cannot be delineated, our findings suggest telemedicine use is compatible with the field of sexual medicine. Rabinowitz MJ, Kohn TP, Ellimoottil C, et al. The Impact of Telemedicine on Sexual Medicine at a Major Academic Center During the COVID-19 Pandemic. Sex Med 2021;9:100366.
Identifiants
pubmed: 34049265
pii: S2050-1161(21)00046-5
doi: 10.1016/j.esxm.2021.100366
pmc: PMC8240353
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100366Subventions
Organisme : AHRQ HHS
ID : K08 HS027632
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2021 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.
Références
J Sex Marital Ther. 2006 Oct-Dec;32(5):401-7
pubmed: 16959663
J Sex Med. 2014 Oct;11(10):2546-53
pubmed: 25059314
Sex Med. 2020 Sep;8(3):370-377
pubmed: 32434669
Eur Urol. 2020 Dec;78(6):812-819
pubmed: 32654801
Sex Med Rev. 2020 Oct;8(4):507-517
pubmed: 32739238
Eur Urol. 2020 Nov;78(5):731-742
pubmed: 32893062
Eur Urol. 2020 Dec;78(6):786-811
pubmed: 32616405
J Sex Med. 2020 Jul;17(7):1220-1221
pubmed: 32493601
Sex Med. 2021 Feb;9(1):100289
pubmed: 33429245
Aesthetic Plast Surg. 2021 Feb;45(1):343-348
pubmed: 32885319
J Med Internet Res. 2020 Apr 6;22(4):e16951
pubmed: 32250280
Eur Urol. 2020 Jul;78(1):16-20
pubmed: 32362498
BMJ. 2004 May 1;328(7447):1037
pubmed: 15051618
J Sex Med. 2009 Aug;6(8):2224-36
pubmed: 19493295
Transl Androl Urol. 2020 Mar;9(Suppl 2):S116-S122
pubmed: 32257852
Clin Gastroenterol Hepatol. 2018 Feb;16(2):157-161.e8
pubmed: 29389489
Am J Manag Care. 2006 Nov;12(13 Suppl):S348-52
pubmed: 17112321
J Med Internet Res. 2020 Nov 5;22(11):e21875
pubmed: 33031047